Inventor · disambiguated record
Frank Peter Stegmeier
Also filed as: STEGMEIER FRANK · STEGMEIER FRANK P · STEGMEIER FRANK PETER
5 granted patents·14 pending applications·7 citations·filing 2011–2024
70Inventor score
Top patents by PatentIndex Score
19 records- 0183US11530413B2Compositions and methods to treat cancerNOVARTIS AG·Filed 2018·Granted Dec 20, 2022·3 cites·6 claims
- 0283US2025270555A1Organic compositions to treat beta-catenin-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0376US2025101435A1Compositions and methods to treat cancerNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0472US9850543B2Biomarkers associated with BRM inhibitionJAGANI ZAINAB·Filed 2014·Granted Dec 26, 2017·4 cites·13 claims
- 0570US2024052354A1Compositions and methods to treat cancerNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0655US2018282728A1Organic compositions to treat beta-catenin-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0752US10329563B2Organic compositions to treat HSF1-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2017·Granted Jun 25, 2019·0 cites·13 claims
- 0852US10023862B2Organic compositions to treat beta-catenin-related diseasesHUESKEN DIETER·Filed 2013·Granted Jul 17, 2018·0 cites·9 claims
- 0952US2019323008A1Organic compositions to treat hsf1-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1051US2023277533A1Therapeutic combinations comprising ubiquitin-specific-processing protease 1 (usp1) inhibitors and poly (adp-ribose) polymerase (parp) inhibitorsKSQ THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1149US2015238515A1Organic compositions to treat kras-related diseasesARROWHEAD RES CORP·Filed 2013·Application pending·0 cites
- 1248US2020347386A1Combination gene targets for improved immunotherapyKSQ THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1347US2018258491A1Biomarkers associated with brm inhibitionJAGANI ZAINAB·Filed 2017·Application pending·0 cites
- 1445US2018153919A1Organic compositions to treat kras-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1543US2016032284A1Organic compositions to treat hsf1-related diseasesCHEN JINYUN·Filed 2012·Application pending·0 cites
- 1639US2015354006A1Markers for acute lymphoblastic leukemiaCHAN HO MAN·Filed 2013·Application pending·0 cites
- 1738US8748428B2Use of a PKC inhibitorSCHULER WALTER·Filed 2011·Granted Jun 10, 2014·0 cites·7 claims
- 1837US2016091485A1Markers for ezh2 inhibitorsCHAN HO MAN·Filed 2014·Application pending·0 cites
- 1929US2018010132A1Inhibition of prmt5 to treat mtap-deficiency-related diseasesNOVARTIS AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Frank Peter Stegmeier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →